[go: up one dir, main page]

AR054844A1 - Vacuna contra lawsonia y metodos de uso de la misma - Google Patents

Vacuna contra lawsonia y metodos de uso de la misma

Info

Publication number
AR054844A1
AR054844A1 ARP060103061A ARP060103061A AR054844A1 AR 054844 A1 AR054844 A1 AR 054844A1 AR P060103061 A ARP060103061 A AR P060103061A AR P060103061 A ARP060103061 A AR P060103061A AR 054844 A1 AR054844 A1 AR 054844A1
Authority
AR
Argentina
Prior art keywords
methods
vaccinating
young animals
lawsonia
protection against
Prior art date
Application number
ARP060103061A
Other languages
English (en)
Inventor
Jeremy Kroll
Michael Roof
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of AR054844A1 publication Critical patent/AR054844A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Métodos de vacunacion mejorados para lograr una mayor proteccion contra ileítis. Los métodos permiten vacunar a animales jovenes, preferentemente lechones, entre 10 y 26 días de vida, vacunar a cerdas prenadas durante la segunda o tercera etapa de gestacion y una combinacion de estos métodos. La vacunacion de las cerdas prenadas puede efectuarse mediante dosis repetidas y/o altas de antígeno de Lawsonia antes de la paricion. Reivindicacion 30: Uso medicinal de una cantidad eficaz de antígeno de Lawsonia intracellularis, caracterizado porque es para la preparacion de un medicamento para vacunar a animales jovenes con una dosis efectiva de una vacuna eficaz para proveer mayor proteccion contra una infeccion por Lawsonia intracellularis, donde dichos animales jovenes tienen entre 10 y 26 días de vida.
ARP060103061A 2005-07-15 2006-07-17 Vacuna contra lawsonia y metodos de uso de la misma AR054844A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69994605P 2005-07-15 2005-07-15
US11/457,039 US8398994B2 (en) 2005-07-15 2006-07-12 Lawsonia vaccine and methods of use thereof

Publications (1)

Publication Number Publication Date
AR054844A1 true AR054844A1 (es) 2007-07-18

Family

ID=37311999

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060103061A AR054844A1 (es) 2005-07-15 2006-07-17 Vacuna contra lawsonia y metodos de uso de la misma

Country Status (15)

Country Link
US (2) US8398994B2 (es)
EP (2) EP2204184B1 (es)
JP (1) JP2009501730A (es)
KR (1) KR20080033411A (es)
AR (1) AR054844A1 (es)
AU (1) AU2006269965A1 (es)
BR (1) BRPI0613039A2 (es)
CA (1) CA2615389A1 (es)
DK (1) DK2204184T3 (es)
ES (1) ES2630023T3 (es)
MX (1) MX2008000349A (es)
RU (1) RU2420310C2 (es)
SG (1) SG163598A1 (es)
TW (1) TW200744631A (es)
WO (1) WO2007011993A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US8470336B2 (en) * 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US20080241190A1 (en) * 2006-11-13 2008-10-02 Boehringer Ingelheim Vetmedica, Inc. Vaccination of horses against lawsonia intracellularis
JP5450407B2 (ja) 2007-07-06 2014-03-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換アミノ−キナゾリノン、前記化合物を含む薬物、それらの使用及び製造方法
WO2009037262A2 (en) 2007-09-17 2009-03-26 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early lawsonia intracellularis infections
US20090233830A1 (en) * 2008-03-14 2009-09-17 Penny Sue Dirr Automatic detergent dishwashing composition
EP2100947A1 (en) 2008-03-14 2009-09-16 The Procter and Gamble Company Automatic dishwashing detergent composition
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
ES2534556T3 (es) * 2008-07-22 2015-04-24 Intervet International Bv Bacteria Lawsonia intracellularis de un nuevo serotipo, vacuna basada en esa bacteria, anticuerpos adecuados para diagnosticar el nuevo serotipo de Lawsonia intracellularis e hibridomas para producir dichos anticuerpos
US8142760B2 (en) * 2008-09-05 2012-03-27 Nathan Len Winkelman Vaccination for Lawsonia intracellularis
US7931975B2 (en) * 2008-11-07 2011-04-26 Global Oled Technology Llc Electroluminescent device containing a flouranthene compound
JP6386999B2 (ja) * 2012-05-17 2018-09-05 ゾエティス・エルエルシー ブタ生殖および呼吸症候群（ｐｒｒｓ）ウイルスに対する離乳前の効果的なワクチン接種
CA2931139C (en) * 2013-12-03 2023-03-14 Intervet International B.V. Swine vaccine against prrs and lawsonia intracellularis
RU2709197C2 (ru) * 2015-02-04 2019-12-17 Интервет Интернэшнл Б.В. Вакцина для применения против субклинической инфекции lawsonia у свиней
CN107206062B (zh) * 2015-02-04 2021-07-02 英特维特国际股份有限公司 用于针对猪中亚临床劳森氏菌感染的疫苗
RU2020140678A (ru) * 2015-10-22 2021-01-27 Интервет Интернэшнл Б.В. Вакцина для защиты mda-позитивного животного от расстройства, возникающего в результате инфекции, вызванной lawsonia intracellularis
KR20180062468A (ko) * 2016-11-18 2018-06-11 녹십자수의약품(주) 신규한 로소니아 인트라셀룰라리스 균주 및 이의 용도
CA3088651A1 (en) * 2018-02-28 2019-09-06 Boehringer Ingelheim Vetmedica Gmbh Method for reducing skatole and/or indole in animals
US12514917B2 (en) * 2019-07-15 2026-01-06 South Dakota Board Of Regents Senecavirus A virus strains and immunogenic compositions therefrom

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
US3479430A (en) * 1967-08-24 1969-11-18 Diamond Lab Inc Indirect passive immunization against transmissible gastroenteritis virus in nursing piglets at birth by active immunization of sows prior to farrowing with transmissible gastroenteritis vaccine and method of producing the same
US3907987A (en) * 1972-05-25 1975-09-23 Canadian Patents Dev Enteric disease vaccine
US4132597A (en) 1976-06-09 1979-01-02 Ab Medipharm Method for cultivation of bacteria
US4237218A (en) 1979-02-09 1980-12-02 Bio-Rad Laboratories, Inc. Micro-carrier cell culture
JPS5991879A (ja) 1982-11-16 1984-05-26 Hideaki Yamada シユ−ドモナス属細菌の培養法
JPS60500673A (ja) 1983-03-08 1985-05-09 コモンウエルス　セラム　ラボラトリ−ズ　コミツシヨン 抗原活性を有するアミノ酸配列
DK594084A (da) 1984-12-12 1986-06-13 Novo Industri As Fremgangsmaade til stabilisering af extra-chromosomale elementer i bakterier under dyrkning
JPH0644865B2 (ja) 1985-10-29 1994-06-15 三菱瓦斯化学株式会社 カンピロバクタ−属細菌の培養方法
US5338670A (en) 1986-07-28 1994-08-16 The United States Of America As Represented By The Department Of Health And Human Services Production of bordetella pertussis toxin with a low concentration of iron
IT1227657B (it) 1988-12-01 1991-04-23 Mini Ricerca Scient Tecnolog Antibiotici ab-021 e processo per la loro produzione
JPH0822221B2 (ja) 1988-12-28 1996-03-06 日東化学工業株式会社 シュードモナス属細菌の培養法
JPH02308754A (ja) 1989-05-24 1990-12-21 Yakult Honsha Co Ltd 乳発酵食品の製造法
US5296221A (en) 1990-01-31 1994-03-22 Sani-Ei Sucrochemical Co., Ltd. Lactobacillus johnsonii ferm bp-2680 lactic acid bacteria preparations using the same and a process of manufacturing the preparations
US5192679A (en) 1990-05-03 1993-03-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Growing ehrlichia species in a continuous cell line
EP0555366B1 (en) 1990-11-01 2000-06-28 Iowa State University Research Foundation, Inc. Bacterial attenuation method and vaccine
DE4208785A1 (de) 1992-03-19 1993-09-23 Degussa Verfahren zum auffinden von insertionselementen (is-elemente) oder transposonen
DE69333588T2 (de) 1992-09-28 2005-08-04 Wyeth Holdings Corp. Verfahren zur verstärkung zellularer immunantworten
US5610059A (en) 1992-11-09 1997-03-11 University Of Arizona Etiological agent for porcine enteritis
US5714375A (en) 1995-06-05 1998-02-03 Nobl Laboratories, Inc. Ileal symbiont intracellularis propagation in suspended host cells
US5885823A (en) * 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
CA2236574A1 (en) 1995-11-30 1997-06-05 Daratech Pty. Ltd. Therapeutic and diagnostic compositions
US20030157120A1 (en) 1999-05-13 2003-08-21 Michael Panaccio Lawsonia derived gene and related flge polypeptides, peptides and proteins and their uses
BR0011292A (pt) 1999-05-13 2002-02-26 Pfizer Prod Inc Gene derivado de lawsonia e proteìnas, peptìdeos e polipeptìdeos sodc relacionados e seus usos
EP1183268A4 (en) 1999-05-13 2003-01-02 Australian Pork Ltd LAWSONIA DERIVED GENES AND RELATED OMPHPOLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
AU775323B2 (en) 1999-05-13 2004-07-29 Agriculture Victoria Services Pty Ltd Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses
NZ515331A (en) 1999-05-13 2003-07-25 Pfizer Prod Inc Lawsonia derived gene and related FlgE polypeptides, peptides and proteins and their uses
US7052697B1 (en) 1999-05-13 2006-05-30 Agriculture Victoria Services Pty Ltd Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses
US6414036B1 (en) 1999-09-01 2002-07-02 Van Beek Global/Ninkov Llc Composition for treatment of infections of humans and animals
EP1094070A3 (en) * 1999-10-22 2002-01-09 Pfizer Products Inc. Lawsonia intracellularis proteins, and related methods and materials
US6605696B1 (en) 1999-10-22 2003-08-12 Pfizer, Inc. Lawsonia intracellularis proteins, and related methods and materials
WO2001089559A2 (en) 2000-05-24 2001-11-29 Merial Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine
MY128159A (en) 2000-06-30 2007-01-31 Wyeth Corp Methods and composition for oral vaccination
EP1324768A2 (en) 2000-09-29 2003-07-09 The Arizona Board of Regents on Behalf of the University of Arizona Vaccines for proliferative ileitis
US20020103261A1 (en) 2000-10-06 2002-08-01 Dusan Ninkov Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals
JP2004512851A (ja) 2000-11-10 2004-04-30 アグリカルチュア　ビクトリア　サービシーズプロプライエトリー　リミティッド ラウソニア種による感染を処置する新規な治療用組成物
ES2360225T3 (es) 2000-12-20 2011-06-02 Intervet International Bv Vacuna contra lawsonia intracellularis.
WO2003000665A1 (de) 2001-06-22 2003-01-03 Bayer Aktiengesellschaft Antibakterielle uracilderivate.
US20030087421A1 (en) 2001-07-11 2003-05-08 Gebhart Connie J Lawsonia intracellularis
EP1570045A4 (en) 2002-10-04 2007-09-05 Univ Minnesota NUCLEIC ACID AND POLYPEPTIDE SEQUENCES FROM LAWSONIA INTRACELLULARIS AND METHOD OF USE
US7312065B2 (en) 2003-07-25 2007-12-25 Boehringer Ingelheim Vetmedica, Inc. Lawsonia intracellularis of European origin and vaccines, diagnostic agents and methods of use thereof
DE602004024423D1 (de) 2003-09-12 2010-01-14 Intervet Int Bv Impfstoff mit lawsonia intracellularis-untereinheit
EP1709067B1 (en) 2004-01-22 2010-06-09 Intervet International BV Lawsonia intracellularis subunit vaccines
MY146476A (en) 2004-06-24 2012-08-15 Boehringer Ingelheim Vetmed Method of diagnosing lawsonia intracellularis
JP5291281B2 (ja) 2004-06-28 2013-09-18 株式会社渡辺商行 浮上搬送装置及び浮上搬送方法
US7550270B2 (en) 2004-08-13 2009-06-23 Boehringer Ingelheim Vetmedica, Inc. Ileitis diagnostic assay
US20070212373A1 (en) 2004-12-08 2007-09-13 Akzo Nobel N.V. Lawsonia Intracellularis 26 Kd Subunit Vaccine
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US20090215698A1 (en) 2005-04-18 2009-08-27 Boehringer Ingelheim Vetmedica, Inc. Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof
US20080279893A1 (en) 2005-04-28 2008-11-13 Boehringer Ingelheim Vetmedica, Inc. Lawsonia intracellularis immunological proteins
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
PL1968630T3 (pl) 2005-12-29 2018-08-31 Boehringer Ingelheim Vetmedica, Inc. Multiwalentne immunogenne kompozycje PCV2
US8470336B2 (en) 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US20080241190A1 (en) 2006-11-13 2008-10-02 Boehringer Ingelheim Vetmedica, Inc. Vaccination of horses against lawsonia intracellularis
WO2009037262A2 (en) 2007-09-17 2009-03-26 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early lawsonia intracellularis infections
US8142760B2 (en) 2008-09-05 2012-03-27 Nathan Len Winkelman Vaccination for Lawsonia intracellularis

Also Published As

Publication number Publication date
RU2420310C2 (ru) 2011-06-10
US20130164332A1 (en) 2013-06-27
MX2008000349A (es) 2008-03-07
US8398994B2 (en) 2013-03-19
DK2204184T3 (en) 2017-07-10
EP2204184A1 (en) 2010-07-07
RU2008105348A (ru) 2009-08-20
KR20080033411A (ko) 2008-04-16
SG163598A1 (en) 2010-08-30
EP1917031A1 (en) 2008-05-07
WO2007011993A1 (en) 2007-01-25
AU2006269965A1 (en) 2007-01-25
CA2615389A1 (en) 2007-01-25
TW200744631A (en) 2007-12-16
EP2204184B1 (en) 2017-04-05
JP2009501730A (ja) 2009-01-22
US20070014815A1 (en) 2007-01-18
WO2007011993B1 (en) 2007-04-12
ES2630023T3 (es) 2017-08-17
BRPI0613039A2 (pt) 2010-12-14

Similar Documents

Publication Publication Date Title
AR054844A1 (es) Vacuna contra lawsonia y metodos de uso de la misma
GT200200138A (es) Vacunacion en dosis unica con mycoplasma hyopneumoniae
DOP2021000127A (es) Composiciones que comprenden conjugados de polisacárido de streptococcus pneumoniae con proteína y sus métodos de uso
AR064363A1 (es) Tratamiento de cerdos con el antigeno pcv
CY1111916T1 (el) Εμβολιο ζωντανου εξασθενημενου ροταϊου για χορηγηση απο του στοματος
CL2004000931A1 (es) Pelicula consumible adaptada para adherirse y disolverse en la cavidad bucal que comprende un almidon modificado y un agente farmaceuticamente activo.
CR11122A (es) Vacuna de influenza de emulsion de aceite en agua
CR9994A (es) Vacuna terapéutica
AR064725A1 (es) Profilaxis y tratamiento del complejo respiratorio porcino (prdc). uso
ECSP21023398A (es) Dosis unitaria de vacuna contra el dengue y administración de esta
CO5611162A2 (es) Metodos para prevenir enfermedades reproductivas en el ganado vacuno
BR112014001409A2 (pt) métodos e composições para vacinação contra staphylococcus aureus
AR089509A1 (es) Metodo para tratar la perdida osea alveolar, un implante dental, un anticuerpo antiesclerostina, un gel o matriz que comprende dicho anticuerpo y uso
ES2695172T3 (es) Vacuna porcina contra SRRP y Lawsonia intracellularis
AR052855A1 (es) Composiciones para el cuidado bucal que contienen un extrato de eucalyptus
AR036355A1 (es) Modelo de exposicion a mycoplasma bovis, para evaluar la eficacia de potenciales vacunas
BR112016012435A8 (pt) vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2
AR042598A1 (es) Composiciones de acetaminofeno
AR053661A1 (es) Peptido para entregar vacunas via mucosas
AR048671A1 (es) Procedimiento de vacunacion contra la infeccion testicular por bvdv
CO2024004886A2 (es) Composiciones de gel inmunógenas
AR047154A1 (es) Tratamiento del insomnio en pacientes humanos administrandoles una cantidad diaria de gaboxadol
RU2010143584A (ru) Вакцина для защиты от haemophilus parasuis серотипа 4 у поросят
ES2625110T3 (es) Tratamiento de infecciones de bolsas subgingivales
RU2213573C2 (ru) Способ профилактики паратифа телят

Legal Events

Date Code Title Description
FB Suspension of granting procedure